Triple
T7031287
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | 340B Drug Pricing Program |
E163275
|
entity |
| Predicate | relatedProgram |
P37
|
FINISHED |
| Object |
Medicaid Drug Rebate Program
The Medicaid Drug Rebate Program is a U.S. federal initiative that requires drug manufacturers to provide rebates to state Medicaid programs in exchange for Medicaid coverage of their outpatient prescription drugs, helping control costs for the program.
|
E637326
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Medicaid Drug Rebate Program | Statement: [340B Drug Pricing Program, relatedProgram, Medicaid Drug Rebate Program]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Medicaid Drug Rebate Program Context triple: [340B Drug Pricing Program, relatedProgram, Medicaid Drug Rebate Program]
-
A.
340B Drug Pricing Program
The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
-
B.
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 is a major U.S. federal law that overhauled Medicare by adding outpatient prescription drug coverage and expanding private plan options for beneficiaries.
-
C.
Prescription Drug User Fee Act of 1992
The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
-
D.
Medicare Part D
Medicare Part D is the U.S. federal program that provides outpatient prescription drug coverage to Medicare beneficiaries through private insurance plans.
-
E.
Center for Program Integrity
The Center for Program Integrity is a division within the Centers for Medicare & Medicaid Services responsible for preventing fraud, waste, and abuse in federal health care programs and ensuring proper payment and program compliance.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Medicaid Drug Rebate Program Triple: [340B Drug Pricing Program, relatedProgram, Medicaid Drug Rebate Program]
Generated description
The Medicaid Drug Rebate Program is a U.S. federal initiative that requires drug manufacturers to provide rebates to state Medicaid programs in exchange for Medicaid coverage of their outpatient prescription drugs, helping control costs for the program.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Medicaid Drug Rebate Program Target entity description: The Medicaid Drug Rebate Program is a U.S. federal initiative that requires drug manufacturers to provide rebates to state Medicaid programs in exchange for Medicaid coverage of their outpatient prescription drugs, helping control costs for the program.
-
A.
340B Drug Pricing Program
The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
-
B.
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 is a major U.S. federal law that overhauled Medicare by adding outpatient prescription drug coverage and expanding private plan options for beneficiaries.
-
C.
Prescription Drug User Fee Act of 1992
The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
-
D.
Medicare Part D
Medicare Part D is the U.S. federal program that provides outpatient prescription drug coverage to Medicare beneficiaries through private insurance plans.
-
E.
Center for Program Integrity
The Center for Program Integrity is a division within the Centers for Medicare & Medicaid Services responsible for preventing fraud, waste, and abuse in federal health care programs and ensuring proper payment and program compliance.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c6885d691c81908cf7d31083113886 |
completed | March 27, 2026, 1:38 p.m. |
| NER | Named-entity recognition | batch_69c6e20ee1208190811be10a84e7d8a4 |
completed | March 27, 2026, 8:01 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c775980920819081d31b8d2843fb3d |
completed | March 28, 2026, 6:30 a.m. |
| NEDg | Description generation | batch_69c77aa1c704819088a9561ac55f9037 |
completed | March 28, 2026, 6:52 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69c77b082f3c8190a649297ce0f816bb |
completed | March 28, 2026, 6:54 a.m. |
Created at: March 27, 2026, 2:35 p.m.